Herbas VPB

Print
EN | LT
LT - CANCER TREATMENT BY COMBINED INHIBITION OF PROTEASOME AND TELOMERASE ACTIVITIES
EN - CANCER TREATMENT BY COMBINED INHIBITION OF PROTEASOME AND TELOMERASE ACTIVITIES

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C12N 15/113
A61K 31/454
A01N 43/04
A01N 61/00
European patent
(11) Number of the document 1876893
(13) Kind of document T
(96) European patent application number 06750227.8
Date of filing the European patent application 2006-04-14
(97) Date of publication of the European application 2008-01-16
(45) Date of publication and mention of the grant of the patent 2012-04-11
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2006/014137
Date 2006-04-14
PCT application publication
(87) Number WO 2006/113470
Date 2006-10-26
Priority applications
(30) Number Date Country code
671630 P 2005-04-15 US
Inventors
(72)
MOORE, Malcolm, A., S., US
CHIN, Allison, C., US
Grantee
(73) GERON CORPORATION, 230 Constitution Drive, Menlo Park, CA 94025, US
MEMORIAL SLOAN-KETTERING CANCER CENTER, 1275 York Avenue, New York, NY 10021, US
Title
(54) CANCER TREATMENT BY COMBINED INHIBITION OF PROTEASOME AND TELOMERASE ACTIVITIES
  CANCER TREATMENT BY COMBINED INHIBITION OF PROTEASOME AND TELOMERASE ACTIVITIES
Last update date 2021-04-30